James Edgemond United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

James Edgemond is CFO AND TREASURER of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 1,578 shares of UTHR, which is worth approximately $434,155. The most recent transaction as insider was on May 15, 2024, when has been sold 40,160 shares (Common Stock) at a price of $272.69 per share, resulting in proceeds of $10,951,230. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.58K
14.02% 3M change
14.02% 12M change
Total Value Held $434,155

JAMES EDGEMOND Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2024
SELL
Open market or private sale
$10,951,230 $272.69 p/Share
40,160 Reduced 96.22%
1,578 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
$6,558,128 $163.3 p/Share
40,160 Added 70.58%
16,738 Common Stock
Nov 07 2022
SELL
Sale (or disposition) back to the issuer
$1,977,254 $266.8 p/Share
7,411 Reduced 84.26%
1,384 Common Stock
Nov 07 2022
BUY
Exercise of conversion of derivative security
$545,004 $73.54 p/Share
7,411 Added 66.13%
3,795 Common Stock
JE

James Edgemond

CFO AND TREASURER
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR